文献速递围术期管理与 ERAS急腹症与外科感染

既往2019冠状病毒病严重程度与大型住院手术后结局相关

Severity of Prior Coronavirus Disease 2019 is Associated With Postoperative Outcomes After Major Inpatient Surgery.
PubMed 文献 · Ann Surg · 2023-07-21

该研究利用美国国家COVID队列协作组数据,纳入2020年1月至2023年2月期间接受大型择期住院手术的387,030例成人患者,其中37,354例(9.7%)术前有COVID-19病史。多因素logistic回归显示,中度和重度SARS-CoV-2感染史即使延迟12周手术仍为术后不良结局的独立危险因素,而轻度COVID-19患者在任何时间点均未增加不良结局风险,接种疫苗可降低呼吸衰竭的比值。

要点

  • 中度或重度COVID-19病史是大型择期住院手术后不良结局的独立危险因素,即使延迟12周手术仍存在。
  • 轻度COVID-19患者在任何时间点均未显示术后不良结局风险增加。
  • 接种疫苗可降低术后呼吸衰竭的比值。

核心结论

  • COVID-19对术后结局的影响取决于疾病严重程度,仅中度和重度疾病导致不良结局风险升高。
  • 现有围术期政策应更新,纳入对COVID-19疾病严重程度和疫苗接种状态的考量。

研究设计与样本

  • 利用美国国家COVID队列协作组(National COVID Cohort Collaborative)数据,纳入2020年1月至2023年2月期间接受大型择期住院手术的成人患者,比较有和无COVID-19病史者的术后结局。
  • 研究共纳入387,030例患者,其中37,354例(9.7%)术前诊断为COVID-19。
  • 将COVID-19严重程度和从感染到手术的时间分别作为自变量,纳入多因素logistic回归模型。

主要发现

  • 在387,030例患者中,37,354例(9.7%)术前有COVID-19诊断。
  • 中度或重度SARS-CoV-2感染史即使延迟12周手术,仍为术后不良结局的独立危险因素。
  • 轻度COVID-19患者在任何时间点均未显示术后不良结局风险增加。
  • 接种疫苗可降低呼吸衰竭的比值。

临床怎么用

  • 现有围术期政策应更新,纳入对COVID-19疾病严重程度和疫苗接种状态的考量。

局限性

  • 原文未报告局限性

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

OBJECTIVE: To determine how the severity of prior history (Hx) of severe acute respiratory syndrome coronavirus-2 (SARS-CoV-2) infection influences postoperative outcomes after major elective inpatient surgery. BACKGROUND: Surgical guidelines instituted early in the coronavirus disease 2019 (COVID-19) pandemic recommended a delay in surgery of up to 8 weeks after an acute SARS-CoV-2 infection. This was based on the observation of elevated surgical risk after recovery from COVID-19 early in the pandemic. As the pandemic shifts to an endemic phase, it is unclear whether this association remains, especially for those recovering from asymptomatic or mildly symptomatic COVID-19. METHODS: Utilizing the National COVID Cohort Collaborative, we assessed postoperative outcomes for adults with and without a Hx of COVID-19 who underwent major elective inpatient surgery between January 2020 and February 2023. COVID-19 severity and time from infection to surgery were each used as independent variables in multivariable logistic regression models. RESULTS: This study included 387,030 patients, of whom 37,354 (9.7%) were diagnosed with preoperative COVID-19. Hx of COVID-19 was found to be an independent risk factor for adverse postoperative outcomes even after a 12-week delay for patients with moderate and severe SARS-CoV-2 infection. Patients with mild COVID-19 did not have an increased risk of adverse postoperative outcomes at any time point. Vaccination decreased the odds of respiratory failure. CONCLUSIONS: Impact of COVID-19 on postoperative outcomes is dependent on the severity of illness, with only moderate and severe disease leading to a higher risk of adverse outcomes. Existing perioperative policies should be updated to include consideration of COVID-19 disease severity and vaccination status.

来源:Ann Surg,查看原文。版权归原作者所有。

引用

  1. Verhagen NB, SenthilKumar G, Jaraczewski T, et al. Severity of Prior Coronavirus Disease 2019 is Associated With Postoperative Outcomes After Major Inpatient Surgery. Ann Surg. 2023. PMID: 37476995. doi:10.1097/SLA.0000000000006035

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。